[Clinical picture and treatment of bronchial asthma comorbid with cardiovascular diseases].
OBJECTIVE
To evaluate prevalence of cardiovascular diseases (CVD) in bronchial asthma (BA) patients and effects of CVD on BA course.


METHODS
Register data for 2005 have been analysed for 5104 BA outpatients living in Krasnoyarsk city (pulmonary ventilation, ECG, echocardiography, duration of BA, number of exacerbations for the last 12 months, number of hospitalizations, disability, BA complications, BA and CVD treatment).


RESULTS
Combination of BA with CVD was observed in 88.3% patients. Severe and moderate BA was in 55 and 44% patients, respectively. 64% BA patients were invalids. CVD were diagnosed more often in patients with detected BA. CVD were treated without allowances for BA. The latter was treated without consideration of its severity and GYNA recommendations. CONCLUSION. To control BA, it is necessary to check up pulmonary function regularly, to diagnose comorbid cardiovascular diseases early, prescrive adequate treatment and teach patients to comply with recommendations.
I V
IV
Demko
N V
NV
Gordeeva
M M
MM
Petrova
I P
IP
Artiukhov
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D015897:Comorbidity; D018450:Disease Progression; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012720:Severity of Illness Index
D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents